Lewis, R. v. Reading Hosp.

2025 Pa. Super. 191
CourtSuperior Court of Pennsylvania
DecidedSeptember 2, 2025
Docket986 MDA 2024
StatusPublished

This text of 2025 Pa. Super. 191 (Lewis, R. v. Reading Hosp.) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lewis, R. v. Reading Hosp., 2025 Pa. Super. 191 (Pa. Ct. App. 2025).

Opinion

J-A07034-25

2025 PA Super 191

RONALD LEWIS : IN THE SUPERIOR COURT OF : PENNSYLVANIA : v. : : : READING HOSPITAL, ROBERT Q. : LUO, M.D., AND TOWER HEALTH : MEDICAL GROUP : No. 986 MDA 2024 : Appellants :

Appeal from the Order Entered June 6, 2024 In the Court of Common Pleas of Berks County Civil Division at No(s): 22 13056

BEFORE: BOWES, J., OLSON, J., and STABILE, J.

OPINION BY STABILE, J.: FILED SEPTEMBER 02, 2025

In this medical malpractice action, Reading Hospital, Robert Q. Luo,

M.D., Tower Health Medical Group (defendants/Appellants) were found liable

for the injuries sustained by Ronald Lewis (plaintiff/Appellee) after he

underwent vascular surgery in 2021. A jury found that Appellants had

negligently deviated from the standard of care when providing post-operative

treatment. Appellee was awarded $869,000 in damages. Appellants now

contend that the verdict must be vacated because the trial court erred in (1)

excluding their expert witness on causation; (2) failing to grant a mistrial after

Appellee’s counsel told the jury that the defense was unable to retain an

expert on causation; (3) allowing Appellee’s expert witness to testify that he

had once been retained in an unrelated case as an expert by Reading Hospital;

and (4) giving an instruction and verdict form to the jury which equated the J-A07034-25

negligence element of factual cause with an “increased risk of harm.” Finding

merit in Appellants’ second and fourth claims, we vacate the order on review

and remand the case for a new trial on those grounds.

On April 6, 2021, Appellee, at the age of 72, underwent open vascular

surgery at Reading Hospital for the purpose of repairing abdominal aortic

aneurisms. Dr. Luo performed the surgery, and soon after it was completed,

Appellee reported severe pain, swelling, and discoloration in his left foot.

It would soon become evident that Appellee’s post-surgery symptoms

were due to a lack of blood flow (ischemia). One likely cause of that type of

ischemic injury was the loosening of plaque (micro-emboli) from Appellee’s

diseased arteries during his vascular surgery.

Rather than treat the ischemic injury immediately after the

manifestation of Appellee’s symptoms, Dr. Luo opted to monitor him to better

ascertain whether and to what extent tissue from his foot would have to be

removed. Dr. Luo believed that there was no viable surgical or medicinal

means of remedying the underlying ischemic injury. Appellee was only

prescribed an antibiotic medication to address a possible bacterial infection

resulting from an apparent burn on Appellee’s left foot which was unrelated to

the vascular surgery.1

Within three weeks of Appellee’s surgery, his left foot developed

gangrene and had to be amputated. Appellee filed a complaint on September ____________________________________________

1 Appellee disputed that he had a burn injury on his left foot at that time, arguing that Appellants had misdiagnosed the burn as a sign of ischemia.

-2- J-A07034-25

6, 2022, alleging that Dr. Luo had been negligent in treating his post-surgery

ischemic injury, resulting in the amputation. Reading Hospital and Tower

Health Medical Group were alleged to be vicariously liable for Dr. Luo’s

negligence. Appellants timely filed an answer and new matter. Appellee then

filed a reply to new matter.

One of the central trial issues was whether Appellants failed to treat

Appellee in accordance with the applicable standard of medical care. Prior to

trial, Appellants produced a report from their expert, Herrick Wun, M.D., a

board-certified vascular surgeon. Dr. Wun obtained an undergraduate degree

from Yale University; medical degrees from the New York University School of

Medicine; and a professorship at the Weill Cornell Medical College, where he

specialized in vascular medicine. He also worked as an attending physician at

the Weill Cornell Medical Center and maintained an active clinical practice.

In his report, Dr. Wun opined that there was no surgical option for

removing the clots in Appellee’s arteries; he further opined that a blood

thinning medication (anticoagulant) would not have prevented the need to

amputate Appellee’s foot:

Anticoagulation is not without its risks and an endpoint is needed once started. There are no guidelines for anticoagulation when the source is atheroembolic disease. In fact, some studies have shown a worse outcome when anticoagulation is given for these situations. Moreover, anticoagulation was not appropriate here because of the risks of bleeding after this open procedure.

Expert Report of Herrick Wun, M.D., December 14, 2023, at 3.

-3- J-A07034-25

The opinion of Dr. Wun differed from that of Appellee’s expert, Timothy

Wu, M.D., a vascular surgeon who opined in his own report that an

anticoagulant should have been administered as soon as Appellee’s symptoms

manifested in his foot. See Expert Report of Timothy Wu, M.D., 10/25/2023,

at 6.2 Dr. Wu stated that the failure to give Appellee such medication breached

the standard of care, increased the risk of harm, and played a role in causing

the need for the foot’s amputation. See id.

Appellee filed a motion in limine on February 23, 2024, to preclude

Appellants’ expert, Dr. Wun, from relying on the unidentified medical literature

referred to in his report. On March 12, 2024, the trial court entered an order

compelling Dr. Wun to name the studies he had relied upon.

Ten days later, on March 22, 2024, Dr. Wun submitted a supplemental

report which failed to comply with the trial court’s directive. He cited no

studies which supported his opinion that anticoagulants may produce a “worse

outcome.” Supplemental Expert Report of Herrick Wun, M.D., 3/22/2024, at

1. Instead, Dr. Wun stated that no particular studies had “come to mind,”

and that it was nevertheless his opinion, “as well as [that of] other experts[,]

that anticoagulation is not beneficial.” Id.

____________________________________________

2 Appellants and Appellee each retained an expert in the field of hematology.

Appellee produced a report by Samuel Berkman, M.D., who opined that an anticoagulant medication should have been given to Appellee; Appellants’ hematology expert, Henry Rinder M.D., opined that an anticoagulant would not have improved Appellee’s condition.

-4- J-A07034-25

On March 27, 2024, Appellee again moved to limit Dr. Wun’s testimony

as a sanction for flouting the trial court’s prior order. The trial court held a

hearing on the motion, and on April 2, 2024, the trial court entered an order

granting Appellee’s motion in limine to preclude Dr. Wun from testifying in

reliance on any medical studies. The trial court heard further argument from

the parties on April 9, 2024, as to whether Dr. Wun would be precluded from

testifying at all as an expert witness. The trial court then entered an order on

that date precluding Dr. Wun from giving any expert opinions.

A few days after that latter order, Appellants moved for reconsideration,

submitting a second supplemental expert report by Dr. Wun, dated April 11,

2024. Disavowing the previously referenced, but unnamed, medical studies

and opinions of other experts, Dr. Wun stated that he was relying only on his

own “education, training, and clinical experience”:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Woods v. Brumlop
377 P.2d 520 (New Mexico Supreme Court, 1962)
Carrozza v. Greenbaum
866 A.2d 369 (Superior Court of Pennsylvania, 2004)
Smith v. Paoli Memorial Hospital
885 A.2d 1012 (Superior Court of Pennsylvania, 2005)
Commonwealth v. Jones
668 A.2d 491 (Supreme Court of Pennsylvania, 1995)
Grady v. Frito-Lay, Inc.
839 A.2d 1038 (Supreme Court of Pennsylvania, 2003)
Toogood v. Rogal
824 A.2d 1140 (Supreme Court of Pennsylvania, 2003)
Primavera v. Celotex Corp.
608 A.2d 515 (Superior Court of Pennsylvania, 1992)
Siegal v. Stefanyszyn
718 A.2d 1274 (Superior Court of Pennsylvania, 1998)
Mitzelfelt v. Kamrin
584 A.2d 888 (Supreme Court of Pennsylvania, 1990)
Winschel v. Jain
925 A.2d 782 (Superior Court of Pennsylvania, 2007)
Miller v. Brass Rail Tavern, Inc.
664 A.2d 525 (Supreme Court of Pennsylvania, 1995)
Millen v. Miller
308 A.2d 115 (Superior Court of Pennsylvania, 1973)
Hamil v. Bashline
392 A.2d 1280 (Supreme Court of Pennsylvania, 1978)
Hickman v. Fruehauf Corp.
563 A.2d 155 (Supreme Court of Pennsylvania, 1989)
Halper v. Jewish Family & Children's Service
963 A.2d 1282 (Supreme Court of Pennsylvania, 2009)
Sutherland v. Monongahela Valley Hospital
856 A.2d 55 (Superior Court of Pennsylvania, 2004)
Feden v. Consolidated Rail Corp.
746 A.2d 1158 (Superior Court of Pennsylvania, 2000)
Corrado v. Thomas Jefferson University Hospital
790 A.2d 1022 (Superior Court of Pennsylvania, 2001)
Wagner v. Anzon, Inc.
684 A.2d 570 (Superior Court of Pennsylvania, 1996)
Kaminski v. Employers Mutual Casualty Co.
487 A.2d 1340 (Supreme Court of Pennsylvania, 1985)

Cite This Page — Counsel Stack

Bluebook (online)
2025 Pa. Super. 191, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lewis-r-v-reading-hosp-pasuperct-2025.